Koyfin Home > Directory > Health Care > Amneal Pharmaceuticals Inc > Total Debt / Equity

Amneal Pharmaceuticals Inc Total Debt / Equity Chart (AMRX)

Amneal Pharmaceuticals Inc annual/quarterly Total Debt / Equity from 2018 to 2018. Debt to equity is a measure of leverage in a company and expressed as a ratio of the total debt relative to book value of equity.
  • Amneal Pharmaceuticals Inc Total Debt / Equity for the quarter ending December 12, 2018 was $300m
  • Amneal Pharmaceuticals Inc Total Debt / Equity for the last 12 months ending December 12, 2018 was $300m
Other Ratios Metrics:
  • Amneal Pharmaceuticals Inc Total Debt / Capital for the quarter ending December 12, 2018 was $75m a -77.49% decrease of -58m year over year
  • Amneal Pharmaceuticals Inc Other Liabilities for the quarter ending December 12, 2018 was $233m a 90.39% increase of 210m year over year
View Chart On Koyfin

Quarterly AMRX Total Debt / Equity Data

12/2018$300m
09/2018$314m
06/2018$292m

Annual AMRX Total Debt / Equity Data

2018$300m